title: Toll-like receptor 4 mediates microglial activation and production of inflammatory mediators in neonatal rat brain following hypoxia: role of TLR4 in hypoxic microglia.
abstract: BACKGROUND
  Hypoxia induces microglial activation which causes damage to the developing brain. Microglia derived inflammatory mediators may contribute to this process. Toll-like receptor 4 (TLR4) has been reported to induce microglial activation and cytokines production in brain injuries; however, its role in hypoxic injury remains uncertain. We investigate here TLR4 expression and its roles in neuroinflammation in neonatal rats following hypoxic injury.
  
  
  METHODS
  One day old Wistar rats were subjected to hypoxia for 2 h. Primary cultured microglia and BV-2 cells were subjected to hypoxia for different durations. TLR4 expression in microglia was determined by RT-PCR, western blot and immunofluorescence staining. Small interfering RNA (siRNA) transfection and antibody neutralization were employed to downregulate TLR4 in BV-2 and primary culture. mRNA and protein expression of tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β) and inducible nitric oxide synthase (iNOS) was assessed. Reactive oxygen species (ROS), nitric oxide (NO) and NF-κB levels were determined by flow cytometry, colorimetric and ELISA assays respectively. Hypoxia-inducible factor-1 alpha (HIF-1α) mRNA and protein expression was quantified and where necessary, the protein expression was depleted by antibody neutralization. In vivo inhibition of TLR4 with CLI-095 injection was carried out followed by investigation of inflammatory mediators expression via double immunofluorescence staining.
  
  
  RESULTS
  TLR4 immunofluorescence and protein expression in the corpus callosum and cerebellum in neonatal microglia were markedly enhanced post-hypoxia. In vitro, TLR4 protein expression was significantly increased in both primary microglia and BV-2 cells post-hypoxia. TLR4 neutralization in primary cultured microglia attenuated the hypoxia-induced expression of TNF-α, IL-1β and iNOS. siRNA knockdown of TLR4 reduced hypoxia-induced upregulation of TNF-α, IL-1β, iNOS, ROS and NO in BV-2 cells. TLR4 downregulation-mediated inhibition of inflammatory cytokines in primary microglia and BV-2 cells was accompanied by the suppression of NF-κB activation. Furthermore, HIF-1α antibody neutralization attenuated the increase of TLR4 expression in hypoxic BV-2 cells. TLR4 inhibition in vivo attenuated the immunoexpression of TNF-α, IL-1β and iNOS on microglia post-hypoxia.
  
  
  CONCLUSIONS
  Activated microglia TLR4 expression mediated neuroinflammation via a NF-κB signaling pathway in response to hypoxia. Hence, microglia TLR4 presents as a potential therapeutic target for neonatal hypoxia brain injuries.
authors: Key Laboratory of the Ministry of Education for Experimental Teratology, Shandong Provincial Key Laboratory of Mental Disorders, Department of Histology and Embryology, Shandong University School of Medicine, 250012, Jinan, China.
authors: Linli
authors: L
authors: Yao
authors: Enci Mary
authors: EM
authors: Kan
authors: Jia
authors: J
authors: Lu
authors: Aijun
authors: A
authors: Hao
authors: S Thameem
authors: ST
authors: Dheen
authors: Charanjit
authors: C
authors: Kaur
authors: Eng-Ang
authors: EA
authors: Ling
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D002470:Cell Survival / Q000502:physiology; D002478:Cells, Cultured; D002534:Hypoxia, Brain / Q000378:metabolism* / Q000473:pathology; D018836:Inflammation Mediators / Q000378:metabolism* / Q000502:physiology; D017628:Microglia / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D051197:Toll-Like Receptor 4 / Q000502:physiology*
chemical_list: D018836:Inflammation Mediators; C495347:Tlr4 protein, rat; D051197:Toll-Like Receptor 4
references: J Biol Chem. 1997 Sep 5;272(36):22642-7
references: 9278421
references: Brain Res Mol Brain Res. 2002 Oct 30;107(1):9-16
references: 12414118
references: J Neuroinflammation. 2005 Oct 07;2:22
references: 16212664
references: Neurosci Lett. 2000 Aug 18;290(1):17-20
references: 10925164
references: Neurology. 2002 Apr 9;58(7):1125-8
references: 11940709
references: J Neuroinflammation. 2011 Aug 09;8:92
references: 21827663
references: Cell Cycle. 2008 Jan 15;7(2):232-41
references: 18212534
references: Nat Rev Immunol. 2002 Oct;2(10):725-34
references: 12360211
references: Glia. 2003 Dec;44(3):183-9
references: 14603460
references: Antioxid Redox Signal. 2008 May;10(5):983-95
references: 18199003
references: Nat Rev Cancer. 2003 Oct;3(10):721-32
references: 13130303
references: J Immunol. 2009 Oct 1;183(7):4733-44
references: 19752239
references: Stroke. 2008 Apr;39(4):1314-20
references: 18309167
references: Clin Sci (Lond). 2003 Jun;104(6):577-84
references: 12589705
references: Nat Med. 2003 Jun;9(6):677-84
references: 12778166
references: J Neurochem. 2006 Aug;98(4):1200-16
references: 16787408
references: J Neuroimmune Pharmacol. 2013 Mar;8(1):66-78
references: 22367679
references: Genes Dev. 2012 Jun 15;26(12):1306-11
references: 22713870
references: Glia. 2013 Jan;61(1):71-90
references: 22674585
references: Mol Cell. 2002 Oct;10(4):693-5
references: 12419209
references: Prog Neurobiol. 2009 Apr;87(4):264-80
references: 19428957
references: Eur J Pharmacol. 2008 Apr 14;584(1):40-8
references: 18299127
references: Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8514-9
references: 12824464
references: Allergol Int. 2006 Jun;55(2):207-12
references: 17075260
references: Br J Nutr. 2012 Jan;107(2):229-41
references: 21733316
references: Nat Protoc. 2008;3(6):1101-8
references: 18546601
references: Science. 2001 Apr 20;292(5516):464-8
references: 11292862
references: Neuroscience. 2011 Sep 29;192:140-54
references: 21729740
references: Clin Ther. 2006 Sep;28(9):1353-65
references: 17062309
references: Neuroscience. 2010 Mar 10;166(1):132-44
references: 20036321
references: Immunology. 2010 Apr;129(4):516-24
references: 20002786
references: J Clin Invest. 2007 Oct;117(10):2847-59
references: 17853945
references: Circulation. 2007 Mar 27;115(12):1599-608
references: 17372179
references: J Clin Invest. 1999 Aug;104(3):271-80
references: 10430608
references: J Immunol. 1993 Aug 15;151(4):2132-41
references: 8102159
references: Mediators Inflamm. 2010;2010:568396
references: 20396414
references: Neurobiol Aging. 2010 Apr;31(4):665-77
references: 18599158
references: World J Gastroenterol. 2010 Jun 21;16(23):2881-8
references: 20556833
references: J Neurosci. 2011 Oct 26;31(43):15450-4
references: 22031891
references: World J Gastroenterol. 2004 Oct 1;10(19):2890-3
references: 15334694
references: J Immunol. 2002 Aug 15;169(4):2069-75
references: 12165534
references: Brain Res. 2002 Apr 12;933(1):23-30
references: 11929632
references: Glia. 2011 Apr;59(4):521-39
references: 21319220
references: J Neurosci. 2002 Apr 1;22(7):2478-86
references: 11923412
references: Neurobiol Dis. 2011 Jan;41(1):138-46
references: 20843479
references: Neuroscience. 2009 Dec 15;164(3):948-62
references: 19712723
references: Anesthesiology. 2011 May;114(5):1130-7
references: 21394006
references: J Neurosci Res. 2007 Jul;85(9):1989-95
references: 17461416
references: Neurosci Lett. 2008 Jan 31;431(2):155-60
references: 18164813
references: Am J Perinatol. 2000;17(7):367-70
references: 12141523